Disorder Name: Dissociative drug dependence including ketamine or PCP
Disorder Code: 1177354811
Code Range: Not specified
Class Kind: category

Standard Definition:
Dissociative drug dependence including ketamine or PCP is a disorder of regulation of dissociative drug use arising from repeated or continuous use of dissociative drugs. The characteristic feature is a strong internal drive to use dissociative drugs, which is manifested by impaired ability to control use, increasing priority given to use over other activities and persistence of use despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to use dissociative drugs. The features of dependence are usually evident over a period of at least 12 months but the diagnosis may be made if dissociative drugs use is continuous (daily or almost daily) for at least 3 months.

Exclusions: Episode of harmful use of dissociative drugs including ketamine or PCP; Harmful pattern of use of dissociative drugs, including ketamine or PCP

Clinical Description and Diagnostic Guidelines:
Clinical Description:
Dissociative drug dependence including ketamine or PCP is a disorder of regulation of dissociative drug use arising from repeated or continuous use of dissociative drugs. The characteristic feature is a strong internal drive to use dissociative drugs, which is manifested by impaired ability to control use, increasing priority given to use over other activities and persistence of use despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to use dissociative drugs. The features of dependence are usually evident over a period of at least 12 months but the diagnosis may be made if dissociative drugs use is continuous (daily or almost daily) for at least 3 months.

Diagnostic Exclusion Criteria:
• Should be differentiated from: Episode of harmful use of dissociative drugs including ketamine or PCP
• Should be differentiated from: Harmful pattern of use of dissociative drugs, including ketamine or PCP

Diagnostic Guidelines:
• Symptom assessment should be conducted within appropriate time frames
• Consider impact of symptoms on personal, family, social, and occupational functioning
• Evaluate symptom severity and duration
• Rule out symptoms due to substance use, medical conditions, or other psychological disorders
• Recommend use of standardized assessment tools and diagnostic criteria

Treatment Considerations:
• Develop individualized treatment plans
• Consider evidence-based treatment approaches
• Refer to specialist treatment when necessary
• Regular monitoring of treatment progress and plan adjustments

For more detailed clinical guidelines, please refer to official ICD-11 documentation.